Selective overexpression of γ1 laminin in astrocytes in amyotrophic lateral sclerosis indicates an involvement in ALS pathology

Journal of Neuroscience Research

Volumn 85, Issue 9, 2007, Pages 2045-2058

  Wiksten, Markus ^a   Väänänen, Antti ^a   Liesi, Päivi ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

1 laminin; Amyotrophic lateral sclerosis; Astrocytes

Indexed keywords

LAMININ GAMMA1; LAMININ;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CERVICAL SPINAL CORD; CONTROLLED STUDY; EXCITOTOXICITY; GRAY MATTER; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; THORACIC SPINAL CORD; WHITE MATTER; ASTROCYTE; BIOSYNTHESIS; CELL SURVIVAL; IMMUNOHISTOCHEMISTRY; METABOLISM; MOTONEURON; PATHOLOGY; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; SPINAL CORD; WESTERN BLOTTING;

AMYOTROPHIC LATERAL SCLEROSIS; ASTROCYTES; BLOTTING, WESTERN; CELL SURVIVAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; IMMUNOHISTOCHEMISTRY; LAMININ; MOTOR NEURONS; SPINAL CORD;

EID: 34447325649     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21314     Document Type: Article

References (71)

1. Aumailley M, Bruckner-Tuderman L, Carter WG, Deutzmann R, Edgar D, Ekblom P, Engel J, Engvall E, Hohenester E, Jones JC, Kleinman HK, Marinkovich MP, Martin GR, Mayer U, Meneguzzi G, Miner JH, Miyazaki K, Patarroyo M, Paulsson M, Quaranta V, Sanes JR, Sasaki T, Sekiguchi K, Sorokin LM, Talts JF, Tryggvason K, Uitto J, Virtanen I, von der Mark K, Wewer UM, Yamada Y, Yurchenco PD. 2005. A simplified laminin nomenclature. Matrix Biol 24:326-332.
2. Barbeito LH, Pehar M, Cassina P, Vargas MR, Peluffo H, Viera L, Estevez AG, Beckman JS. 2004. A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis. Brain Res Rev 47:263-274.
3. Barber SC, Mead RJ, Shaw PJ. 2006. Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target. Biochim Biophys Acta [E-pub ahead of print].
4. Bove J, Prou D, Perier C, Przedborski S. 2005. Toxin-induced models of Parkinson's disease. J Am Soc Exp Neurother 2:484-494.
5. Bowser R, Cudkowicz M, Kaddurah-Daouk R. 2006. Biomarkers for amyotrophic lateral sclerosis. Expert Rev Mol Diagn 6:387-398.
6. Bruijn LI, Miller TM, Cleveland DW. 2004. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci. 27:723-749.
7. Chen ZL, Strickland S. 1997. Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell 91:917-925.
8. Chen ZL, Indyk JA, Strickland S. 2003. The hippocampal laminin matrix is dynamic and critical for neuronal survival. Mol Biol Cell 14:2665-2676.
9. Choi DW. 1988. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:623-634.
10. Choi DW. 1994. Glutamate receptors and the induction of excitotoxic neuronal death. Prog Brain Res 100:47-51.
11. Cohen G, Heikkila RE. 1974. The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, daluric acid, and related cytotoxic agents. J Biol Chem 249:2447-2452.
12. Cote F, Collard JF, Julien JP. 1993. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model of amyotrophic lateral sclerosis. Cell 73:35-46.
13. Czaplinski A, Yen AA, Appel SH. 2006. Amyotrophic lateral sclerosis: early predictors of prolonged survival. J Neurol [E-pub ahead of print].
14. Dib M. 2003. Amyotrophic lateral sclerosis: progress and prospects for treatment. Drugs 63:289-310.
15. Doherty MJ, Bird TD, Leverenz JB. 2004. Alpha-synuclein in motor neuron disease: an immunohistologic study. Acta Neuropathol 107:169-175.
16. Engel J. 1991. Domains in proteins and proteoglycans of the extracellular matrix with functions in assembly and cellular activities. Int J Biol Macromol 13:147-151.
17. Fujita K, Kato T, Yamauchi M, Ando M, Honda M, Nagata Y. 1998. Increases in fragmented glial fibrillary acidic protein levels in the spinal cords of patients with amyotrophic lateral sclerosis. Neurochem Res 23:169-174.
18. Gregory R, Mills K, Donaghy M. 1993. Progressive sensory nerve dysfunction in amyotrophic lateral sclerosis: a prospective clinical and neurophysiological study. J Neurol 240:309-314.
19. Gu Z, Cui J, Brown S, Fridman R, Mobashery S, Strongin AY, Lipton SA. 2005. A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. J Neurosci 25:6401-6408.
20. Hadano S, Hand CK, Osuga H, Yanagisawa Y, Otomo A, Devon RS, Miyamoto N, Showguchi-Miyata J, Okada Y, Singaraja R, Figlewicz DA, Kwiatkowski T, Hosler BA, Sagie T, Skaug J, Nasir J, Brown RH Jr, Scherer SW, Rouleau GA, Hayden MR, Ikeda JE. 2001. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat Genet 29:166-173.
21. Hand CK, Rouleau GA. 2002. Familial amyotrophic lateral sclerosis. Muscle Nerve 25:135-159.
22. Hirano A. 1996. Neuropathology of ALS: an overview. Neurology 47:S63-S66.
23. Jacquier A, Buhler E, Schafer MK, Bohl D, Blanchard S, Beclin C, Haase G. 2006. Alsin/Rac1 signaling controls survival and growth of spinal motoneurons. Ann Neurol 60:105-117.
24. Kato S, Takikawa M, Nakashima K, Hirano A, Cleveland DW, Kusaka H, Shibata N, Kato M, Nakano I, Ohama E. 2000. New consensus research on neuropathological aspects of familial amyotrophic lateral sclerosis with superoxide dismutase 1 (SOD1) gene mutations: inclusions containing SOD1 in neurons and astrocytes. Amyotroph Lateral Scler Other Motor Neuron Disord 1:163-184.
25. Kawamoto Y, Akiguchi I, Nakamura S, Budka H. 2004. 14-3-3 Proteins in Lewy body-like hyaline inclusions in patients with sporadic amyotrophic lateral sclerosis. Acta Neuropathol 108:531-537.
26. Kikuchi H, Yamada T, Furuya H, Doh-ura K, Ohyagi Y, Iwaki T, Kira J. 2003. Involvement of cathepsin B in the motor neuron degeneration of amyotrophic lateral sclerosis. Acta Neuropathol 105:462-468.
27. Kim SH, Henkel JS, Beers DR, Sengun IS, Simpson EP, Goodman JC, Engelhardt JI, Siklos L, Appel SH. 2003. PARP expression is increased in astrocytes but decreased in motor neurons in the spinal cord of sporadic ALS patients. J Neuropathol Exp Neurol 62:88-103.
28. Kuncl RW, Crawford TO, Rothstein JD, Drachman DB. 1992. Motor neuron disease. In: Asbury AK, McKhann GM, McDonald WI, editors. Diseases of the nervous system: clinical neurobiology, 2nd ed. Philadelphia: W.B. Saunders Company. p 1179-1208.
29. Lariviere RC, Julien JP. 2004. Functions of intermediate filaments in neuronal development and disease. J Neurobiol 58:131-148.
30. Lee MK, Cleveland DW. 1994. Neurofilament function and dysfunction: involvement in axonal growth and neuronal disease. Curr Opin Cell Biol 6:34-40.
31. Liebkind R, Laatikainen T, Liesi P. 2003. Is the soluble KDI domain of gammal laminin a regeneration factor for the mammalian central nervous system? J Neurosci Res 73:637-643.
32. Liesi P. 1990. Extracellular matrix and neuronal movement. Exprentia 46:900-907.
33. Liesi P, Kauppila T. 2002. Induction of type IV collagen and other basement-membrane-associated proteins after spinal cord injury of the adult rat may participate in formation of the glial scar. Exp Neurol 173:31-45.
34. Liesi P, Wright JM. 1996. Weaver granule neurons are rescued by calcium channel antagonists and antibodies against a neurite outgrowth domain of the B2 chain of laminin. J Cell Biol 134:477-486.
35. Liesi P, Närvänen A, Soos J, Sariola H, Snounou G. 1989. Identification of neurite outgrowth-promoting domain of laminin using synthetic peptides. FEBS Lett 224:141-148.
36. Liesi P, Hager G, Dodt HU, Seppälä I, Zieglgänsberger W. 1995. Domain specific antibodies against a neurite outgrowth domain of the B2 chain of laminin inhibit neuronal migration in neonatal rat cerebellum. J Neurosci Res 40:199-206.
37. Liesi P, Fried G, Stewart RR. 2001a. Neurons and glial cells of the embryonic human brain and spinal cord express multiple and distinct isoforms of laminin. J Neurosci Res 64:144-167.
38. Liesi P, Laatikainen T, Wright JM. 2001b. Biologically active sequence (KDI) mediates the neurite outgrowth function of the gamma-1 chain of laminin-1. J Neurosci Res 66:1047-1053.
39. Lim GP, Backstrom JR, Cullen MJ, Miller CA, Atkinson RD, Tokes ZA. 1996. Matrix metalloproteinases in the neocortex and spinal cord of amyotrophic lateral sclerosis patients. J Neurochem 67:251-259.
40. Lipton SA. 2004. Sporadic ALS: blame it on the editor. Nat Med 10:347.
41. Llado J, Haenggeli C, Pardo A, Wong V, Benson L, Coccia C, Rothstein JD, Shefner JM, Maragakis NJ. 2006. Degeneration of respiratory motor neurons in the SOD1 G93A transgenic rat model of ALS. Neurobiol Dis 21:110-118.
42. Ludolph AC. 2006. Matrix metalloproteinases - a conceptual alternative for disease-modifying strategies in ALS/MND? Exp Neurol 201:277-280.
43. Magnus T, Beck M, Giess R, Puls I, Naumann M, Toyka KV. 2002. Disease progression in amyotrophic lateral sclerosis: predictors of survival. Muscle Nerve 25:709-714.
44. Mattson MP. 2003. Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders. Neuromol Med 3:65-95.
45. Mattson MP. 2004. Metal-catalyzed disruption of membrane protein and lipid signaling in the pathogenesis of neurodegenerative disorders. Ann N Y Acad Sci 1012:37-50.
46. Matsuzawa M, Weight FF, Potember RS, Liesi P. 1996. Directional neurite outgrowth and axonal differentiation of embryonic hippocampal neurons are promoted by a neurite outgrowth domain of the B2-chain of laminin. Int J Dev Neurosci 14:283-295.
47. Matsuzawa M, Tokumitsu S, Knoll W, Liesi P. 1998. Molecular gradient along the axon pathway is not reguired for directional axon growth. J Neurosci Res 53:114-124.
48. Millecamps S, Gentil BJ, Gros-Louis F, Rouleau G, Julien JP. 2005. Alsin is partially associated with centrosome in human cells. Biochim Biophys Acta 1745:84-100.
49. Mondelli M, Rossi A, Passero S, Guazzi GC. 1993. Involvement of peripheral sensory fibers in amyotrophic lateral sclerosis: electrophysiological study of 64 cases. Muscle Nerve 16:166-72.
50. Möykkynen T, Liebkind R, Sjoberg J, Korpi ER, Liesi P. 2005. The neuroprotective KDI domain of gamma 1-laminin is a universal and potent inhibitor of ionotropic glutamate receptors. J Neurosci Res 81:797-804.
51. Murtomäki S, Risteli J, Risteli L, Koivisto UM, Johansson S, Liesi P. 1992. Laminin and its neurite outgrowth-promoting domain in the brain in Alzheimer's disease and Down's syndrome patients. J Neurosci Res 32:261-273.
52. Nagai N, Urano T, Endo A, Takahashi H, Takada Y, Takada A. 1999. Neuronal degeneration and a decrease in laminin-like immunoreactivity is associated with elevated tissue-type plasminogen activator in the rat hippocampus after kainic acid injection. Neurosci Res 33:147-154.
53. Ono S, Imai T, Shimizu N, Nagao K. 2000. Increased expression of laminin 1 in the skin of amyotrophic lateral sclerosis. Eur Neurol 43:215-220.
54. Ott U, Odermatt E, Engel J, Furtmayr H, Timpl R. 1982. Protease resistance and conformation of laminin. Eur J Biochem 173:629-635.
55. Palu E, Liesi P. 2002. Differential distribution of laminins in Alzheimer disease and normal human brain tissue. J Neurosci Res 69:243-256.
56. Pasinelli P, Brown RH. 2006. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat Rev Neurosci 710:710-723.
57. Pasinelli P, Borchelt DR, Houseweart MK, Cleveland DW, Brown RH Jr. 1998. Caspase-1 is activated in neural cells and tissue with amyotrophic lateral sclerosis-associated mutations in copper-zinc superoxide dismutase. Proc Natl Acad Sci U S A 95:15763-15768.
58. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX, Rahmani Z, Krizus A, McKenna-Yasek D, Cayabyab A, Gaston SM, Berger R, Tanzi RE, Halperin JJ, Herzfeldt B, Van den Bergh R, Hung WY, Bird T, Deng G, Mulder DW, Smyth C, Laing NG, Soriano E, Pericak-Vance MA, Haines J, Rouleau GA, Gusella JS, Horvitz HR, Brown RH Jr. 1993. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59-62.
59. Sattler R, Tymianski M. 2001. Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death. Mol Neurobiol 24:107-129.
60. Schiffer D, Cordera S, Cavalla P, Migheli A. 1996. Reactive astrogliosis of the spinal cord in amyotrophic lateral sclerosis. J Neurol Sci 139(Suppl):27-33.
61. Selverstone Valentine J, Doucette PA, Zittin Potter S. 2005. Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis. Annu Rev Biochem 74:563-593.
62. Tandan R, Bradley WG. 1985. Amyotrophic lateral sclerosis: part 1. Clinical features, pathology, and ethical issues in management. Ann Neurol 18:271-280.
63. Tateno M, Sadakata H, Tanaka M, Itohara S, Shin RM, Miura M, Masuda M, Aosaki T, Urushitani M, Misawa H, Takahashi R. 2004. Calcium-permeable AMPA receptors promote misfolding of mutant SOD1 protein and development of amyotrophic lateral sclerosis in a transgenic mouse model. Hum Mol Genet 13:2183-2196.
64. Tortarolo M, Grignaschi G, Calvaresi N, Zennaro E, Spaltro G, Colovic M, Fracasso C, Guiso G, Elger B, Schneider H, Seilheimer B, Caccia S, Bendotti C. 2006. Glutamate AMPA receptors change in motor neurons of SOD1G93A transgenic mice and their inhibition by a non-competitive antagonist ameliorates the progression of amytrophic lateral sclerosis-like disease. J Neurosci Res 83:134-146.
65. Troy CM, Salvesen GS. 2002. Caspases on the brain. J Neurosci Res 69:145-150.
66. Väänänen AJ, Rauhala P, Tuominen RK, Liesi P. 2006. KDI tripeptide of gamma1 laminin protects rat dopaminergic neurons from 6-OHDA induced toxicity. J Neurosci Res 84:655-665.
67. Van Den Bosch L, Van Damme P, Bogaert E, Robberecht W. 2006. The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. Biochim Biophys Acta [E-pub ahead of print].
68. Wiksten M, Liebkind R, Laatikainen T, Liesi P. 2003. Gamma 1 laminin and its biologically active KDI-domain may guide axons in the floor plate of human embryonic spinal cord. J Neurosci Res 71:338-352.
69. Wiksten M, Väänänen AJ, Liebkind R, Liesi P. 2004a. Regeneration of adult spinal cord is promoted by the soluble KDI-domain of γ1 laminin. J Neurosci Res 78:403-410.
70. Wiksten M, Väänänen AJ, Liebkind R, Rauhala P, Liesi P. 2004b. Soluble KDI-domain of γ1 laminin protects adult rat hippocampus from excitotoxicity of kainic acid. J Neurosci Res 78:411-419.
71. Xu Z, Cork LC, Griffin JW, Cleveland DW. 1993. Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell 73:23-33.